About Dr. Rajagopal

Dr. Leena Rajagopal is a double-board-certified psychiatrist in General Adult Psychiatry and Forensic Psychiatry. With a diverse background in clinical care, forensic psychiatry, and medical education, she brings extensive expertise to Elevium Health.

Dr. Rajagopal first completed her psychiatric training in her home country, India, before immigrating to the United States, where she completed her General Adult Psychiatry residency at the Icahn School of Medicine at Mount Sinai, Elmhurst Hospital Center. Recognized for her leadership, she was selected as chief resident in her final year. She then pursued a Forensic Psychiatry fellowship at Albert Einstein College of Medicine, further deepening her expertise in the intersection of mental health and the legal system.

Following her training, Dr. Rajagopal served as Director of Forensic Services at NYC Health + Hospitals, Elmhurst, where she oversaw the clinical and administrative operations of forensic psychiatry services. She also played a pivotal role in curriculum development, clinical training, and mentorship for psychiatry residents, psychology interns, and medical students. She continues to be actively involved in forensic psychiatry training while providing care for forensic patient populations in New Jersey and New York State Hospital systems.

With a strong commitment to psychiatric education and training, Dr. Rajagopal has been instrumental in shaping the next generation of psychiatrists, particularly in the complexities of psychiatric diagnosis, treatment, and care delivery. Her dedication to academic excellence and mentorship strengthens Elevium Health’s mission to provide cutting-edge psychiatric care and advance the field of mental health.

At Elevium Health, Dr. Rajagopal brings a nuanced and patient-centered approach to mental health care, integrating cutting-edge treatments such as TMS, Spravato, and Ketamine therapy. Having completed specialized training in TMS and Ketamine therapy, she is particularly interested in how these emerging modalities can offer new hope for individuals facing complex and treatment-resistant conditions. Her work is guided by a deep understanding of mental health and trauma, allowing her to provide care that is both scientifically grounded and highly personalized. As the field of psychiatry continues to evolve, she remains committed to exploring new therapeutic frontiers, including the potential of psychedelic-assisted therapies, to expand access to transformative mental healthcare.